134 related articles for article (PubMed ID: 20464324)
21. [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].
Rammeh-Rommani S; Zermani R; Sfaxi M; Chabchoub A; Zouari B; Ayed M; Ben Jilani-Baltagi S
Tunis Med; 2007 Jun; 85(6):509-12. PubMed ID: 17644907
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
23. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group.
Walterhouse DO; Pappo AS; Baker KS; Parham DM; Anderson JR; Donaldson SS; Paidas CN; Womer RB; Crist WM
Cancer; 2001 Dec; 92(12):3135-46. PubMed ID: 11753993
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological analysis of head and neck rhabdomyosarcoma: A series of 10 cases and literature review.
Pontes FS; de Oliveira JI; de Souza LL; de Almeida OP; Fregnani ER; Vilela RS; Silva WM; Fonseca FP; Pontes HA
Med Oral Patol Oral Cir Bucal; 2018 Mar; 23(2):e188-e197. PubMed ID: 29476676
[TBL] [Abstract][Full Text] [Related]
25. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of p53 protein in rhabdomyosarcoma: association with clinicopathological features and outcome.
Ayan I; Dŏgan O; Kebudi R; Bavbek B; Alatli C; Dervişoğlu S; Dişçi R; Demiryont M
J Pediatr Hematol Oncol; 1997; 19(1):48-53. PubMed ID: 9065719
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical study of PCNA, EGFR, c-erbB-2 and p53 in carcinomas of large intestine].
Yamagiwa H; Onishi N; Onishi T; Onishi T; Onishi H; Watanabe K; Kadowaki Y; Nishii M; Kato Y
Rinsho Byori; 1995 Jul; 43(7):703-7. PubMed ID: 7674543
[TBL] [Abstract][Full Text] [Related]
28. [Immunohistochemical study of PCNA, p53 gene product and c-erbB-2 gene product in endometrial carcinoma].
Miyazaki M
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Apr; 48(4):269-76. PubMed ID: 8936111
[TBL] [Abstract][Full Text] [Related]
29. Juvenile (embryonal and alveolar) rhabdomyosarcoma of the head and neck in adults. A clinical, pathologic, and immunohistochemical study of 12 cases.
Nakhleh RE; Swanson PE; Dehner LP
Cancer; 1991 Feb; 67(4):1019-24. PubMed ID: 1991249
[TBL] [Abstract][Full Text] [Related]
30. Childhood rhabdomyosarcoma: a review of 35 cases and literature.
Mandong BM; Ngbea JA
Niger J Med; 2011; 20(4):466-9. PubMed ID: 22288325
[TBL] [Abstract][Full Text] [Related]
31. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
Mielcarek-Kuchta D; Olofsson J; Golusinski W
Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784
[TBL] [Abstract][Full Text] [Related]
32. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of proliferating cell nuclear antigen immunostaining in pediatric rhabdomyosarcomas.
Tokuç G; Doğan O; Ayan I; Kebudi R; Doğan S; Demiryont M; Camlica H
Acta Paediatr Jpn; 1998 Dec; 40(6):573-9. PubMed ID: 9893293
[TBL] [Abstract][Full Text] [Related]
34. Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas.
Edgren M; Eriksson B; Wilander E; Westlin JE; Nilsson S; Oberg K
Anticancer Res; 1997; 17(2B):1303-9. PubMed ID: 9137490
[TBL] [Abstract][Full Text] [Related]
35. The combination of p53 and age predict cancer specific death in advanced stage (FIGO Ic-IV) of endometrial carcinoma of endometrioid type. An immunohistochemical examination of growth fraction: Ki-67, MIB-1 and PC10; suppressor oncogene protein: p53; oncogene protein: p185 and age, hormone treatment, stage, and histologic grade.
Nielsen AL; Nyholm HC
Eur J Obstet Gynecol Reprod Biol; 1996 Dec; 70(1):79-85. PubMed ID: 9031925
[TBL] [Abstract][Full Text] [Related]
36. Orbital tumors in USA: difference in survival patterns.
Hassan WM; Alfaar AS; Bakry MS; Ezzat S
Cancer Epidemiol; 2014 Oct; 38(5):515-22. PubMed ID: 25052531
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
Ben Rejeb A; Mahjoub A; Berraies N; Tissaoui K
Ann Urol (Paris); 2000 Aug; 34(4):240-8. PubMed ID: 10994143
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt.
el-A Helal T; Khalifa A; Kamel AS
Anticancer Res; 2000; 20(3B):2145-50. PubMed ID: 10928168
[TBL] [Abstract][Full Text] [Related]
39. Rhabdomyosarcoma in All Age Groups at the Jos University Teaching Hospital.
Innocent E; Manasseh AN; Badoe EV; Daniel Y; Vandi KB; Olanrewaju A; Graham EU
West Afr J Med; 2018; 35(2):97-101. PubMed ID: 30027994
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological study of 145 childhood rhabdomyosarcoma cases].
He LJ; Wang L; Sun N; Huang CR; Zhu XD; Lang ZQ
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):225-8. PubMed ID: 15256113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
